NUS AI platform enables doctors to optimise personalised chemotherapy dose
Based on a pilot clinical trial, close to 97% of dose recommendations by CURATE.AI were accepted by clinicians; some patients were prescribed optimal doses that were around 20% lower on averageA team of researchers from National University of Singapore…